Bioventix PLC
LSE:BVXP
Bioventix PLC
LSE:BVXP
Price:
4 375 GBX
Market Closed
Updated:
May 17, 2024
Bioventix PLC
Income from Continuing Operations
|
Bioventix PLC
Income from Continuing Operations Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bioventix PLC
LSE:BVXP
|
Income from Continuing Operations
£8.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Income from Continuing Operations
-$151.1m
|
CAGR 3-Years
-142%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Income from Continuing Operations
-$208.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Income from Continuing Operations
-$168.2m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Income from Continuing Operations
-£55.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Income from Continuing Operations
£30.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Bioventix PLC's Income from Continuing Operations?
Income from Continuing Operations
8.7m
GBP
8.7m
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's Income from Continuing Operations amounts to 8.7m GBP.
What is Bioventix PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
18%
18%
Over the last year, the Income from Continuing Operations growth was 3%. The average annual Income from Continuing Operations growth rates for Bioventix PLC have been 9% over the past three years , 9% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
